BNP Paribas Financial Markets
IDIX

BNP Paribas Financial Markets’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

BNP Paribas Financial Markets’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,170
Closed -$28.2K – 4493
2014
Q2 		$28.2K Buy
+1,170
New +$12.2K ﹤0.01% 2227
2014
Q1 		– Sell
-1,294
Closed -$7.74K – 4184
2013
Q4 		$7.74K Sell
1,294
-24,943
-95% -$115K ﹤0.01% 2810
2013
Q3 		$136K Sell
26,237
-7,872
-23% -$34.5K ﹤0.01% 2364
2013
Q2 		$123K Buy
+34,109
New +$139K ﹤0.01% 2489

BNP Paribas Financial Markets's IDIX Position: Q3 2014 in Review

BNP Paribas Financial Markets sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 1,170 shares — an estimated $28.2K sold.

BNP Paribas Financial Markets first reported a position in IDIX in Q2 2013 and held it in 4 quarters. The position peaked at $136K in Q3 2013. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • BNP Paribas Financial Markets reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 1,170 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $28.2K.
  • BNP Paribas Financial Markets first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 4 quarters.
  • BNP Paribas Financial Markets's IDENIX PHARMACEUTICALS INC position peaked at $136K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2014, filed 12 Nov 2014.